Company
Melbourne, VIC
Every investor coverage indicates participated in a round Bio-Gene Technology raised.
Companies Bio-Gene Technology acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Richard Jagger | CEO & Managing Director | @AuManufacturing |
| Tim Grogan | CEO & Managing Director | @AuManufacturing |
Stories naming Bio-Gene Technology. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne agtech Bio-Gene Technology completed a A$3.28 million equity raise, closing the second tranche of a 2025 placement, with shareholders also approving options for participants and the deal's lead manager.
Roundup of manufacturing news: Namoi Cotton agrees a takeover scheme with Louis Dreyfus, Bio-Gene receives an R&D tax payment, SPEE3D and NIOA appoint executives, and Cicada opens workshop applications.
Roundup of manufacturing news: Vaxxas secures CEPI funding and a CRC-P grant, Hastings gains an increased NAIF loan, Bio-Gene receives an R&D tax incentive, plus jobs data and a skills consultation.